CLEARPOINT NEURO INC
ClearPoint Neuro (CLPT) develops MRI-guided platforms and instruments used in precision neurosurgery and targeted brain drug delivery. Its ClearPoint System enables real-time MRI visualisation during stereotactic procedures, helping clinicians place devices or deliver therapies such as intraparenchymal convection-enhanced delivery (CED). Revenue comes from system sales, single-use disposables and service contracts, plus partnerships with biopharma for therapy delivery. Investors often watch ClearPoint for clinical adoption trends, trial readouts and commercial partnerships that could broaden use cases. The company operates in a specialised, capital-intensive segment of medical devices where regulatory approvals, hospital purchasing cycles and reimbursement policies influence uptake. As a small-cap medical technology firm, ClearPoint can offer upside if its technology becomes standard in certain neurosurgical workflows, but faces execution and funding risks. This summary is educational only and not personal financial advice; values can rise or fall and past performance does not predict future returns.
Stock Performance Snapshot
Analyst Rating
Analysts suggest buying Clearpoint Neuro's stock, expecting it to rise to $29 in value.
Financial Health
ClearPoint Neuro is generating decent revenue and cash flow, but faces challenges in profitability.
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Discover More Opportunities
Agilent Technologies Inc.
Agilent Technologies, Inc. specializes in life sciences, diagnostics and applied markets, providing application-focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. Its segments include Life Sciences and Diagnostics Markets, Agilent CrossLab and Applied Markets. The Life Sciences and Diagnostics Markets segment provides contract development and manufacturing services for pharmaceutical customers as well as solutions that include reagents, instruments, software and consumables which enable customers in the clinical and life sciences research areas to interrogate samples at the cellular and molecular level. The Agilent CrossLab segment spans the entire lab with its services and consumables portfolio in addition to software and laboratory automation solutions, which are designed to improve customer outcomes and represent a range of offerings designed to serve customer needs across end-markets and applications.
Align Technology Inc.
Align Technology is a medical device company that designs, manufactures and markets a range of dental and orthodontic products.
Avantor Inc
Avantor, Inc. is a life science tools company and global provider of mission-critical products and services to the life sciences and advanced technology industries. The Company’s segments include Laboratory Solutions and Bioscience Production. Within its segments, it sells materials and consumables, equipment and instrumentation and services and specialty procurement to customers in the biopharma and healthcare, education and government and advanced technologies and applied materials industries. Materials and consumables include ultra-high purity chemicals and reagents, lab products and supplies, highly specialized formulated silicone materials, customized excipients, and others. Equipment and instrumentation include filtration systems, virus inactivation systems, incubators, analytical instruments, and others. Services and specialty procurement include onsite lab and production, equipment, procurement and sourcing and biopharmaceutical material scale-up and development services.
Baskets Featuring CLPT
Safer Alzheimer's Treatments
This carefully selected group of stocks represents companies at the forefront of developing safer, more effective Alzheimer's treatments. The FDA's recent approval of improved dosing for breakthrough therapies has created significant new opportunities in this rapidly evolving field.
Published: July 11, 2025
Explore BasketBrain-Computer Interface
This collection features pioneering companies creating revolutionary pathways between the human brain and machines. These carefully selected stocks represent the cutting edge of neural technology, with potential to transform healthcare and computing through innovative brain signal interpretation.
Published: June 17, 2025
Explore BasketWhy You’ll Want to Watch This Stock
Clinical Adoption Trend
Growing use of MRI-guided procedures could expand the addressable market, though adoption depends on hospital budgets, training and reimbursement.
Partnered Therapies
Collaborations for targeted drug delivery (CED) may create new revenue streams; clinical and regulatory hurdles can affect timing and outcomes.
Market Positioning
A specialised small-cap player with unique technology—offers potential upside if uptake increases, but expect volatility and funding risks.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
